Skip to main content
. 2016 May 16;6:25984. doi: 10.1038/srep25984

Figure 3. Forest plots showing the clinical outcome of the eligible trials comparing low-molecular weight heparin to the usual treatment.

Figure 3

APACHE II score (A); 28-day mortality (B); length of intensive care unit stay (C).